195 related articles for article (PubMed ID: 17134614)
21. Liver genomic responses to ciguatoxin: evidence for activation of phase I and phase II detoxification pathways following an acute hypothermic response in mice.
Morey JS; Ryan JC; Bottein Dechraoui MY; Rezvani AH; Levin ED; Gordon CJ; Ramsdell JS; Van Dolah FM
Toxicol Sci; 2008 Jun; 103(2):298-310. PubMed ID: 18353800
[TBL] [Abstract][Full Text] [Related]
22. Expression profiling of selected genes of toxication and detoxication pathways in peripheral blood lymphocytes as a biomarker for predicting toxicity of environmental chemicals.
Sharma A; Saurabh K; Yadav S; Jain SK; Parmar D
Int J Hyg Environ Health; 2013 Nov; 216(6):645-51. PubMed ID: 23273579
[TBL] [Abstract][Full Text] [Related]
23. Indian studies on genetic polymorphisms and cancer risk.
Bag A; Jyala NS; Bag N
Indian J Cancer; 2012; 49(1):144-62. PubMed ID: 22842182
[TBL] [Abstract][Full Text] [Related]
24. Genetic basis of toxic reactions to drugs and chemicals.
Cascorbi I
Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
[TBL] [Abstract][Full Text] [Related]
25. Drug metabolism in the paediatric population and in the elderly.
Benedetti MS; Whomsley R; Canning M
Drug Discov Today; 2007 Aug; 12(15-16):599-610. PubMed ID: 17706541
[TBL] [Abstract][Full Text] [Related]
26. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphism of CYP1A1, CYP2D6, GSTM1 and GSTT1 and susceptibility to acute lymphoblastic leukaemia in Indian children.
Joseph T; Kusumakumary P; Chacko P; Abraham A; Radhakrishna Pillai M
Pediatr Blood Cancer; 2004 Oct; 43(5):560-7. PubMed ID: 15382273
[TBL] [Abstract][Full Text] [Related]
28. Metabolic polymorphisms and cancer susceptibility.
Smith G; Stanley LA; Sim E; Strange RC; Wolf CR
Cancer Surv; 1995; 25():27-65. PubMed ID: 8718512
[TBL] [Abstract][Full Text] [Related]
29. Nutrition, genetics, and risks of cancer.
Rock CL; Lampe JW; Patterson RE
Annu Rev Public Health; 2000; 21():47-64. PubMed ID: 10884945
[TBL] [Abstract][Full Text] [Related]
30. Gene-environment interactions in esophageal cancer.
Matejcic M; Iqbal Parker M
Crit Rev Clin Lab Sci; 2015; 52(5):211-31. PubMed ID: 26220475
[TBL] [Abstract][Full Text] [Related]
31. The carotenoid lycopene differentially regulates phase I and II enzymes in dimethylbenz[a]anthracene-induced MCF-7 cells.
Wang H; Leung LK
Nutrition; 2010; 26(11-12):1181-7. PubMed ID: 20400267
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of smoking-related carcinogen detoxifying enzymes and head and neck cancer susceptibility.
Lacko M; Oude Ophuis MB; Peters WH; Manni JJ
Anticancer Res; 2009 Feb; 29(2):753-61. PubMed ID: 19331232
[TBL] [Abstract][Full Text] [Related]
33. Characterization of xenobiotic metabolizing enzymes of a reconstructed human epidermal model from adult hair follicles.
Bacqueville D; Jacques C; Duprat L; Jamin EL; Guiraud B; Perdu E; Bessou-Touya S; Zalko D; Duplan H
Toxicol Appl Pharmacol; 2017 Aug; 329():190-201. PubMed ID: 28601433
[TBL] [Abstract][Full Text] [Related]
34. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
35. Drug-metabolizing enzymes, polymorphisms and interindividual response to environmental toxicants.
Nebert DW
Clin Chem Lab Med; 2000 Sep; 38(9):857-61. PubMed ID: 11097340
[TBL] [Abstract][Full Text] [Related]
36. [Cancer chemotherapy and drug metabolism enzyme].
Xu F; Zhen YS; Shao RG
Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):295-8. PubMed ID: 16408765
[TBL] [Abstract][Full Text] [Related]
37. Effect of perfluorodecalin on activities of hepatic phase II xenobiotic biotransformation enzymes.
Kalinina EV; Obraztsov VV; Shekhtman DG; Gudkova OV; Kukushkin NI; Saprin AN
Biochem Int; 1991 Jun; 24(3):543-8. PubMed ID: 1772431
[TBL] [Abstract][Full Text] [Related]
38. Metabolism of xenobiotics and chemical carcinogenesis.
Lang M; Pelkonen O
IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
[TBL] [Abstract][Full Text] [Related]
39. Xenobiotic-metabolizing enzymes in human lung.
Zhang JY; Wang Y; Prakash C
Curr Drug Metab; 2006 Dec; 7(8):939-48. PubMed ID: 17168693
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation of genes for xenobiotic-metabolizing enzymes and risk of bronchial asthma: the importance of gene-gene and gene-environment interactions for disease susceptibility.
Polonikov AV; Ivanov VP; Solodilova MA
J Hum Genet; 2009 Aug; 54(8):440-9. PubMed ID: 19575027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
